Association between human leukocyte antigen polymorphism and human papillomavirus 16-positive vulval intraepithelial neoplasia in British women

Cancer Research

Volumn 63, Issue 2, 2003, Pages 400-403

  Davidson, Emma J ^a,b   Davidson, Judith A ^c   Sterling, Jane C ^d   Baldwin, Peter J W ^d   Kitchener, Henry C ^b   Stern, Peter L ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b ST MARY S HOSPITAL   (United Kingdom)

^c MANCHESTER ROYAL INFIRMARY   (United Kingdom)

^d UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIGEN CLASS 1; HLA B7 ANTIGEN; HLA DQB1 ANTIGEN; HLA DR ANTIGEN; UNCLASSIFIED DRUG; VIRUS VACCINE; WART VIRUS VACCINE;

ARTICLE; BIOPSY; CADAVER; CANCER RISK; CARCINOMA IN SITU; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DISEASE ASSOCIATION; FEMALE; GENE FREQUENCY; GENETIC POLYMORPHISM; HISTOPATHOLOGY; HUMAN; HUMAN PAPILLOMAVIRUS TYPE 16; HUMAN TISSUE; IMMUNOGENETICS; MALIGNANT TRANSFORMATION; PRIORITY JOURNAL; VULVA CANCER; VULVA INTRAEPITHELIAL NEOPLASIA; WART VIRUS;

BIOPSY; FEMALE; HLA-A ANTIGENS; HLA-DR ANTIGENS; HUMANS; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; POLYMORPHISM, GENETIC; TUMOR VIRUS INFECTIONS; VULVAR NEOPLASMS;

EID: 0037439692     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (22)

1. van Beurden, M., ten Kate, F. J., Smits, H. L., Berkhout, R. J., de Craen, A. J., van der Vange, N., Lammes, F. B., and ter Schegget, J. Multifocal vulvar intraepithelial neoplasia grade 111 and multicentric lower genital tract neoplasia is associated with transcriptionally active human papillomavirus. Cancer (Phila.), 75: 2879-2884, 1995.
2. Remmink, A. J., Walboomers, J. M. M., Helmerhorst, T. M., Voorhorst, F. J., Rozendaal, L., Risse, E. J. K., Meijer, C. J. L. M., and Kenemans, P. The presence of persistent high-risk HPV genotypes in dysplastic cervical lesions is associated with progressive disease: natural history up to 36 months. Int. J. Cancer, 61: 306-311, 1995.
3. Spitzer, M. Lower genital tract intraepithelial neoplasia in HIV-infected women: guidelines for evaluation and management. Obstet. Gynecol. Surv., 54: 131-137, 1999.
4. Konya, J., and Dillner, J. Immunity to oncogenic human papillomaviruses. Adv. Cancer Res., 82: 205-238, 2001.
5. Wank, R., and Thomssen, C. High risk of squamous cell carcinoma of the cervix for women with HLA-DQw3. Nature (Lond.), 352: 723-725, 1991.
6. Apple, R. J., Erlich, H. A., Klitz, W., Manos, M. M., Becker, T. M., and Wheeler, C. M. HLA DR-DQ associations with cervical carcinoma show papillomavirus type-specificity. Nat. Genet., 6: 157-162, 1994.
7. Duggan-Keen, M. F., Keating, P. J., Stevens, F. R. A., Sinnott, P., Snijders, P. J. F., Walboomers, J. M. M., Davidson, S., Hunter, R. D., Dyer, P. A., and Stern, P. L. Immunogenetic factors in HPV-associated cervical cancer: influence on disease progression. Eur. J. Immunogenet., 23: 275-284, 1996.
8. Hildesheim, A., Schiffman, M., Scott, D. R., Marti, D., Kissner, T., Sherman, M. E., Glass, A. G., Manos, M. M., Lorincz, A. T., Kurman, R. J., Buckland, J., Rush, B. B., and Carrington, M. Human leukocyte antigen class I/II alleles and development of human papillomavirus-related cervical neoplasia: results from a case-control study conducted in the United States. Cancer Epidemiol. Biomark. Prev., 7: 1035-1041, 1998.
9. Bontkes, H. J., van Duin, M., De Gruijl, T. D., Duggan-Keen, M. F., Walboomers, J. M. M., Stukart, M. J., Verhiejen, R. H. M., Helmerhorst, T. J. M., Meijer, C. J. L. M., Scheper, R. J., Stevens, F. R. A., Dyer, P. A., Sinnott, P., and Stern, P. L. HPV 16 infection and progression of cervical intraepithelial neoplasia: analysis of HLA polymorphism and HPV 16 E6 sequence variants. Int. J. Cancer, 78: 166-171, 1998.
10. Cuzick, J., Terry, G., Ho, L., Monaghan, J., Lopes, A., Clarkson, P., and Duncan, I. Association between high-risk HPV types. HLA DRB1* and DQB1* alleles and cervical cancer in British women. Br. J. Cancer, 82: 1348-1352, 2000.
11. Beskow, A. H., Josefsson, A. M., and Gyllensten, U. B. HLA class II alleles associated with infection by HPV16 in cervical cancer in situ. Int. J. Cancer, 93: 817-822, 2001.
12. Zehbe, I., Tachezy, R., Mytilineos, J., Voglino, G., Mikyskova, I., Delius, H., Marongiu, A., Gissmann, L., Wilander, E., and Tommasino, M. Human papillomavirus 16 E6 polymorphisms in cervical lesions from different European populations and their correlation with human leukocyte antigen class II haplotypes. Int. J. Cancer, 94: 711-716, 2001.
13. Jones, R. W., and Rowan, D. M. Vulvar intraepithelial neoplasia III: a clinical study of the outcome in 113 cases with relation to the later development of invasive vulvar carcinoma. Obstet. Gynecol., 84: 741-745, 1994.
14. Joura, E. A., Losch, A., Haider-Angeler, M. G., Breitenecker, G., and Leodolter, S. Trends in vulvar neoplasia. Increasing incidence of vulvar intraepithelial neoplasia and squamous cell carcinoma of the vulva in young women. J. Reprod. Med., 45: 613-615, 2000.
15. Stern, P. L., Faulkner, R., Veranes, E. C., and Davidson, E. J. The role of human papillomavirus vaccines in cervical neoplasia. Best Pract. Res. Obstet. Gynaecol., 15: 783-799, 2001.
16. Abdel-Hady, E. S., Martin-Hirsch, P., Duggan-Keen, M., Stern, P. L., Moore, J. V., Corbitt, G., Kitchener, H. C., and Hampson, I. N. Immunological and viral factors associated with the response of vulval intraepithelial neoplasia to photodynamic therapy. Cancer Res., 61: 192-196, 2001.
17. Montoya, L., Saiz, I., Rey, G., Vela, F., and Clerici-Larradet, N. Cervical carcinoma: human papillomavirus infection and HLA-associated risk factors in the Spanish population. Eur. J. Immunogenet., 25: 329-337, 1998.
18. Bontkes, H. J., Walboomers, J. M. M., Meijer, C. J. L. M., Helmerhorst, T. J. M., and Stern, P. L. Specific HLA class I down-regulation is an early event in cervical dysplasia associated with clinical progression. Lancet, 351: 187-188, 1998.
19. Perneger, T. V. What's wrong with Bonferroni adjustments? BMJ, 316: 1236-1238, 1998.
20. Syrjanen, K. J. Natural history of genital human hapillomavirus infections. In: C. Lacey (ed.) Papillomavirus Reviews: Current Research on Papillomaviruses. pp. 189-206. Leeds: Leeds University Press, 1996.
21. Biron, C. A. Role of early cytokines, including α and β interferons (IFN-α/β), in innate and adaptive immune responses to viral infections. Semin. Immunol., 10: 383-390, 1998.
22. Read, S., and Powrie, F. CD4(+) regulatory T cells. Curr. Opin. Immunol., 3: 644-649, 2001.